Position in TLRY
as of Mar 31, 2026
· filed May 21, 2026
Position Value
$57,058
+$56,986 QoQ
Shares Held
8,819
+110137.5% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TLRY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Essential Partners LLC holds $1,343,606 across 34 Drug Manufacturers - Specialty & Generic names. TLRY ranks #5 (4.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
5,469 | $720,486 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
333 | $197,462 | |
| 3 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
1,926 | $92,736 | |
| 4 | IRWD |
Ironwood Pharmaceuticals Inc
|
22,102 | $77,578 | |
| 5 | TLRY |
Tilray Brands, Inc.
This page
|
8,819 | $57,058 | |
| 6 | AMRX |
Amneal Pharmaceuticals, Inc.
|
3,227 | $40,111 | |
| 7 | BCRX |
Biocryst Pharmaceuticals Inc
|
3,886 | $36,994 | |
| 8 | VTRS |
Viatris Inc
|
2,505 | $33,842 |
All Filings in TLRY
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $57,058 | 8,819 | Shares | Sole | 2026-05-21 | |
| 2025-12-31 | $72 | 8 | Shares | Sole | 2026-05-21 | |
| 2025-09-30 | $1,453 | 84 | Shares | Sole | 2026-05-21 | |
| No filing history on record for this holder in this stock. | ||||||